Monday, August 17, 2020

Novavax begins mid-stage study of COVID-19 vaccine in South Africa

Novavax begins mid-stage study of COVID-19 vaccine in South Africa The Phase 2b trial study of NVX-CoV2373 will be conducted on about 2,665 healthy adults and will evaluate the safety and immunogenicity in about 240 medically stable, HIV-positive adults, the company said in a statement.

from Moneycontrol Business News https://ift.tt/2E6lcCm
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...